Oxurion NV (formerly known as ThromboGenics NV), a biopharmaceutical company developing treatments to preserve...
Up to date
Appointments
Zelluna Immunotherapy has announced the appointment of Geir Christian Melen as chief financial officer (CFO).
Aglaris Ltd. yesterday announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish...
Exscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of...
Pfizer Inc. today announced its Board of Directors has unanimously elected Dr. Albert Bourla, 56, Pfizer Chief...
Ysios Capital, a biotechnology venture capital firm in Spain, today announced that it has appointed Guillem...
Share
